Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Clinical trial NCT06223568 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06223568
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck Oropharynx Human Papillomavirus Viruses Drug Therapy Cancer Vaccine

Start date: 2024-06-10
Primary completion: 2028-01-10
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.